AO extract (250 mg/kg) significantly reversed the suppression of hepatic FXR protein production by WD for 52 weeks; indeed, its treatment improved the pathological manifestations of NAFLD and metabolic syndrome. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.